Cancer
Malignant Prostate Neoplasm
CI-CAN-00005927Explore in graph →
Top-level1,377 active trials24 approved drugs58 evidence items
- NCIt
- C7378
- ICD-10
- C61
- DOID
- 10283
- Other
- 2 more codes
Loading cancer entity…
Loading cancer entity…
Cancer
CI-CAN-00005927Explore in graph →
Clinical trials
5,979 studies whose conditions map to this entity or one of its descendants. Status and phase are as posted on ClinicalTrials.gov. 50 studies per page.
Computedformula ci-trial-intel-v1 · interventional studies · entity + NCIt descendants · hover a figure for its formulaCompare cancersTerminated studies (730)
| NCT | Title | Status | Phase | Enrollment (n) | Sponsor | Countries | Last update | Source |
|---|---|---|---|---|---|---|---|---|
| NCT00448695 | MRI Targeted Focal Laser Thermal Therapy of Biopsy Confirmed Prostate Cancer | completed | Phase 1 | 12 | University Health Network, TorontoOTHER | 1 | Jun 15, 2012 | clinicaltrials |
| NCT00895115 | Vitamin E Supplements in Preventing Cancer in Patients at Risk of Prostate Cancer or Who Have Prostate Cancer | completed | Phase 1 | 65 | University of Medicine and Dentistry of New JerseyOTHER | 1 | Jun 14, 2012 |
| NCT00313456 | A Phase I Study of the Oral Platinum Agent Satraplatin in Combination With Weekly Docetaxel | terminated | Phase 1 | 25 | AgennixINDUSTRY | 1 | May 10, 2012 | clinicaltrials |
| NCT00005827 | Genistein in Treating Patients With Stage II, Stage III, or Stage IV Prostate Cancer | withdrawn | Phase 1 | 0 | UNC Lineberger Comprehensive Cancer CenterOTHER | 1 | Apr 24, 2012 | clinicaltrials |
| NCT00480623 | A Phase I Trial of Satraplatin Plus Radiation Therapy for Prostate Cancer Patients With Biochemical Recurrence | terminated | Phase 1 | — | AgennixINDUSTRY | 1 | Mar 23, 2012 | clinicaltrials |
| NCT00653757 | Intensity-Modulated Radiation Therapy in Treating Patients With Stage I, Stage II, Stage III, or Stage IV Prostate Cancer | completed | Phase 1 / Phase 2 | 100 | Mayo ClinicOTHER | 1 | Mar 19, 2012 | clinicaltrials |
| NCT00054977 | Safety of GM-CT-01 With and Without 5-Fluorouracil in Patients With Solid Tumors | completed | Phase 1 | 40 | Galectin Therapeutics Inc.INDUSTRY | 1 | Mar 12, 2012 | clinicaltrials |
| NCT01048151 | TNFerade Biologic to Treat Locally Advanced Prostate Cancer | unknown | Phase 1 | 20 | GenVecINDUSTRY | 1 | Mar 12, 2012 | clinicaltrials |
| NCT00989105 | Technetium Tc 99m Demobesin-4 for Imaging Procedures in Patients With Prostate Cancer | terminated | Phase 1 | 8 | Cancer Research UKOTHER | 1 | Feb 28, 2012 | clinicaltrials |
| NCT00217516 | Selenium in Treating Patients Who Are Undergoing Brachytherapy for Stage I or Stage II Prostate Cancer | completed | Phase 1 | 18 | Roswell Park Cancer InstituteOTHER | 1 | Feb 9, 2012 | clinicaltrials |
| NCT00698711 | Vaccination of Prostate Cancer Patients With MUC-2-KLH Conjugate Plus the Immunological Adjuvant QS21 | completed | Phase 1 | 15 | Memorial Sloan Kettering Cancer CenterOTHER | 1 | Jan 31, 2012 | clinicaltrials |
| NCT01132404 | Study in Men With Prostate Cancer to Assess the Safety, Pharmacokinetics and Testosterone-Lowering Efficacy of TAK-448 | terminated | Phase 1 / Phase 2 | 9 | Millennium Pharmaceuticals, Inc.INDUSTRY | 1 | Jan 31, 2012 | clinicaltrials |
| NCT00126165 | Short-course Hypofractionated Radiotherapy for Localized Prostate Cancer | completed | Phase 1 / Phase 2 | 72 | Alberta Health servicesOTHER | 1 | Jan 19, 2012 | clinicaltrials |
| NCT01510288 | Phase 1 Trial of Ipilimumab and GVAX in Patients With Metastatic Castration-resistant Prostate Cancer | terminated | Phase 1 | 28 | Amsterdam UMC, location VUmcOTHER | 1 | Jan 16, 2012 | clinicaltrials |
| NCT00705835 | Vaccine Therapy of Prostate Cancer Patients With Recombinant Soluble Prostate-Specific Membrane Antigen (Rs-PSMA) Plus the Immunological Adjuvant Alhydrogel | completed | Phase 1 | 14 | Memorial Sloan Kettering Cancer CenterOTHER | 1 | Jan 9, 2012 | clinicaltrials |
| NCT01153113 | Human Telomerase Reverse Transcriptase Messenger RNA (hTERT mRNA) Transfected Dendritic Cell Vaccines | withdrawn | Phase 1 / Phase 2 | 0 | University of FloridaOTHER | 0 | Dec 2, 2011 | clinicaltrials |
| NCT00712829 | Study to Evaluate the Safety, Pharmacokinetics, Tissue Distribution, Metabolism and Dosimetry of Two Prostate Cancer Imaging Agents | completed | Phase 1 | 12 | Molecular Insight Pharmaceuticals, Inc.INDUSTRY | 1 | Oct 12, 2011 | clinicaltrials |
| NCT00992745 | A Phase I Pilot Study Comparing 123I MIP 1072 Versus 111In Capromab Pendetide in Subjects With Metastatic Prostate Cancer | completed | Phase 1 | 24 | Molecular Insight Pharmaceuticals, Inc.INDUSTRY | 1 | Oct 12, 2011 | clinicaltrials |
| NCT00129025 | Hypofractionated Radiotherapy (55 Gy/16 Fractions/4 Weeks) for Localized Prostate Cancer | completed | Phase 1 / Phase 2 | 35 | Alberta Health servicesOTHER | 1 | Oct 10, 2011 | clinicaltrials |
| NCT00003038 | Combination Chemotherapy With Suramin Plus Doxorubicin in Treating Patients With Advanced Solid Tumors | completed | Phase 1 | — | Mayo ClinicOTHER | 1 | Aug 3, 2011 | clinicaltrials |
| NCT00003690 | Flavopiridol Plus Cisplatin or Carboplatin in Treating Patients With Advanced Solid Tumors | completed | Phase 1 | 48 | Mayo ClinicOTHER | 1 | Aug 3, 2011 | clinicaltrials |
| NCT00625430 | A Phase I Gene Therapy Study of FP253/Fludarabine for Prostate Cancer(FP253-GDEPT) | unknown | Phase 1 | 18 | Biotech Equity Partners Pty LtdINDUSTRY | 1 | Jul 11, 2011 | clinicaltrials |
| NCT00286793 | Safety and Efficacy Study of AT-101 in Combination With Docetaxel and Prednisone in Men With HRPC | completed | Phase 1 / Phase 2 | 76 | Ascenta TherapeuticsINDUSTRY | 1 | Jun 29, 2011 | clinicaltrials |
| NCT01225471 | Novel Peptide Vaccination for Patients With Advanced Prostate Cancer | unknown | Phase 1 / Phase 2 | 30 | Iwate Medical UniversityOTHER | 1 | Jun 23, 2011 | clinicaltrials |
| NCT00405210 | Pharmacokinetic Study of BAY43-9006 and Taxotere to Treat Patient With Prostatic Cancer | completed | Phase 1 | 38 | Cliniques universitaires Saint-Luc- Université Catholique de LouvainOTHER | 2 | May 23, 2011 | clinicaltrials |
| NCT00667641 | Paclitaxel and Bortezomib in Treating Patients With Metastatic or Unresectable Malignant Solid Tumors | completed | Phase 1 | 16 | University of Medicine and Dentistry of New JerseyOTHER | 1 | May 10, 2011 | clinicaltrials |
| NCT00716794 | A Phase I/II Study of HE3235 in Patients With Prostate Cancer | completed | Phase 1 / Phase 2 | 64 | Harbor TherapeuticsINDUSTRY | 1 | Mar 9, 2011 | clinicaltrials |
| NCT00326586 | A Phase I Dose-Escalation Study of BMS-641988 in Patients With Castration-Resistant Prostate Cancer | completed | Phase 1 | 54 | Bristol-Myers SquibbINDUSTRY | 1 | Jan 25, 2011 | clinicaltrials |
| NCT00644488 | A Phase I Study of BMS-641988 in Japanese Patients With Castration Resistant Prostate Cancer | completed | Phase 1 | 7 | Bristol-Myers SquibbINDUSTRY | 1 | Jan 25, 2011 | clinicaltrials |
| NCT00502164 | Study to Assess Safety and Tolerability of AZD2171 After Multiple Doses in Patients With Advanced Prostate Cancer(AZD2171IL/0003) | completed | Phase 1 | 40 | AstraZenecaINDUSTRY | 1 | Jan 21, 2011 | clinicaltrials |
| NCT00252941 | Prophylactic Urethral Stenting With Memokath After Prostate Implantation for Prostate Adenocarcinoma | completed | Phase 1 / Phase 2 | 20 | The Cleveland ClinicOTHER | 1 | Dec 21, 2010 | clinicaltrials |
| NCT00264420 | Safety and Efficacy Study of Concomitant Radiotherapy and Zoledronic Acid for Bone Metastases Palliation | completed | Phase 1 | 4 | The Cleveland ClinicOTHER | 0 | Dec 21, 2010 | clinicaltrials |
| NCT00541788 | Evaluation of the Efficacy and Safety of Common Sage in Controlling Hot Flashes in Prostate Cancer Patients Treated by Androgen Deprivation | completed | Phase 1 | 10 | University Hospital, GhentOTHER | 1 | Sep 17, 2010 | clinicaltrials |
| NCT00415779 | ZANTE: Zometa and Taxotere in Hormone Refractory Prostate Cancer(ZANTE) | completed | Phase 1 | 36 | National Cancer Institute, NaplesOTHER | 1 | Feb 24, 2010 | clinicaltrials |
| NCT00909558 | Safety and Effectiveness Study of Autologous Natural Killer and Natural Killer T Cells on Cancer | suspended | Phase 1 | 24 | Envita Medical Center, Inc.INDUSTRY | 1 | Feb 24, 2010 | clinicaltrials |
| NCT00084526 | Computed Tomography (CT) Scans Using CT-On-Rails™ to Pinpoint the Location of the Tumor in Treating Patients With Prostate Cancer | completed | Phase 1 / Phase 2 | 40 | Fox Chase Cancer CenterOTHER | 1 | Feb 12, 2010 | clinicaltrials |
| NCT00003391 | Monoclonal Antibody Therapy in Treating Patients With Prostate Cancer That Has Not Responded to Hormone Therapy | completed | Phase 1 | 30 | Weill Medical College of Cornell UniversityOTHER | 1 | Oct 12, 2009 | clinicaltrials |
| NCT00465725 | A Study Comparing Oral Picoplatin With Intravenous Picoplatin in Subjects With Solid Tumors | completed | Phase 1 | 18 | Poniard PharmaceuticalsINDUSTRY | 1 | Sep 24, 2009 | clinicaltrials |
| NCT00928603 | Investigative Study of the Role of Focal Therapy for Prostate Cancer Treatment | unknown | Phase 1 | 100 | Università Vita-Salute San RaffaeleOTHER | 1 | Sep 15, 2009 | clinicaltrials |
| NCT00895466 | Efficacy and Safety Study of the Therapeutic Vaccine PEP223 in Prostate Cancer Patients | unknown | Phase 1 / Phase 2 | 12 | Pepscan TherapeuticsINDUSTRY | 1 | May 8, 2009 | clinicaltrials |
| NCT00379132 | 131-I-TM-601 Study in Adults With Solid Tumors | completed | Phase 1 | 60 | TransMolecularINDUSTRY | 1 | Mar 31, 2009 | clinicaltrials |
| NCT00695851 | Dose-Seeking Trial of PCK3145 in Asymptomatic, Castrate Metastatic Prostate Cancer Patients. | completed | Phase 1 | 36 | Memorial Sloan Kettering Cancer CenterOTHER | 1 | Mar 30, 2009 | clinicaltrials |
| NCT00122005 | GVAX in Advanced Prostate Cancer Patients Made Lymphopenic | unknown | Phase 1 / Phase 2 | 18 | Providence Health & ServicesOTHER | 1 | Feb 24, 2009 | clinicaltrials |
| NCT00108264 | Tumor RNA Transfected Dendritic Cell Vaccines | completed | Phase 1 | — | US Department of Veterans AffairsFED | 1 | Jan 21, 2009 | clinicaltrials |
| NCT00559429 | Study of Docetaxel +153 Sm-EDTMP in Patients With Hormone-Refractory Prostate Cancer(Tax-Sam) | completed | Phase 1 | 13 | Sidney Kimmel Comprehensive Cancer Center at Johns HopkinsOTHER | 1 | Dec 17, 2008 | clinicaltrials |
| NCT00338026 | A Phase I Study of ECO-4601 in Patients With Advanced Cancer | completed | Phase 1 | 26 | Thallion PharmaceuticalsINDUSTRY | 1 | Jul 15, 2008 | clinicaltrials |
| NCT00406939 | Vector Delivery of the IL-12 Gene in Men With Prostate Cancer | completed | Phase 1 | 4 | Baylor College of MedicineOTHER | 1 | Jul 10, 2008 | clinicaltrials |
| NCT00087854 | Study of Individualized Amonafide to Treat Prostate Cancer | completed | Phase 1 / Phase 2 | 40 | Xanthus Pharmaceuticals, Inc.INDUSTRY | 1 | Apr 23, 2008 | clinicaltrials |
| NCT00140348 | Dose Escalation and Efficacy Trial of GVAX® Prostate Cancer Vaccine | completed | Phase 1 / Phase 2 | 80 | Cell GenesysINDUSTRY | 1 | Dec 24, 2007 | clinicaltrials |
| NCT00283829 | Immunotherapy After Chemotherapy for Patients With Hormone Refractory Metastatic Prostate Cancer | completed | Phase 1 / Phase 2 | 30 | University of WashingtonOTHER | 1 | Nov 29, 2007 | clinicaltrials |
Data updated 22 days agoSource updated Jun 15, 2012source: clinicaltrials